To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions

Healthy

Interventions

DRUG

JW2286

a single administration of JW2286 per dose

DRUG

Placebo of JW2286

a single administration of Placebo of JW2286 per dose

Trial Locations (1)

RECRUITING

Seoul National University Hospital Clinical Trial Center, Seoul